| Mon, 10 Aug 2020 20:35:18: | WuXi Biologics taps veteran insider to head fledging vaccine CDMO business
|
| Mon, 10 Aug 2020 15:12:34: | Teva's Ajovy, chasing Amgen and Lilly drugs, gains steam after autoinjector rollout
|
| Mon, 10 Aug 2020 13:42:30: | FiercePharmaPolitics—After drug pricing tensions, industry pushes back at Trump's 'Buy American' order
|
| Mon, 10 Aug 2020 13:20:27: | Kodak's $765 million manufacturing loan on the rocks as red flags multiply
|
| Sun, 09 Aug 2020 22:46:04: | Pfizer, Moderna and Gilead's reputations climb on COVID-19 vaccine and treatment news: poll
|
| Sat, 08 Aug 2020 10:38:24: | WCLC: Lilly, Innovent tout Tyvyt front-line lung cancer win. Can it challenge Merck’s Keytruda?
|
| Fri, 07 Aug 2020 22:31:52: | WCLC: Bristol Myers' Opdivo-Yervoy duo slashes mesothelioma death risk by 26%
|
| Fri, 07 Aug 2020 18:39:45: | Roche gets a green light to challenge Biogen, Novartis with SMA med Evrysdi
|
| Fri, 07 Aug 2020 14:46:42: | Takeda teams up with Novavax to introduce its coronavirus vaccine in Japan
|
| Fri, 07 Aug 2020 14:36:27: | Pfizer signs up to help manufacture Gilead's scarce coronavirus-fighter remdesivir
|
| Fri, 07 Aug 2020 12:57:20: | FiercePharmaAsia—COVID vax deals by AstraZeneca in China, Pfizer-BioNTech in Japan; new Legend CEO
|
| Fri, 07 Aug 2020 07:03:09: | Roche swings and misses with another Tecentriq-chemo combo in tough-to-treat breast cancer
|
| Thu, 06 Aug 2020 14:59:11: | Alexion hires first chief diversity officer, following pharma peers and social sentiment
|
| Thu, 06 Aug 2020 14:51:03: | Analysts to Bristol Myers Squibb: Can I-O hit Opdivo really return to growth?
|
| Thu, 06 Aug 2020 14:49:55: | Trump to issue ‘Buy American’ executive order for essential drugs: reports
|
| Thu, 06 Aug 2020 14:03:54: | Novo Nordisk, unscathed by COVID-19, enters 'strike mode' with diabetes launch Rybelsus
|
| Thu, 06 Aug 2020 13:49:41: | House Dems launch probe into Kodak's unexpected $765M drug manufacturing loan from the feds
|
| Thu, 06 Aug 2020 09:52:34: | AstraZeneca takes COVID-19 vaccine to China with BioKangtai deal for 200M-dose capacity by 2021
|
| Thu, 06 Aug 2020 06:48:54: | GlaxoSmithKline jumps into myeloma with 'homemade' anti-BCMA drug Blenrep
|
| Wed, 05 Aug 2020 20:42:38: | Takeda hustles to prevent cancer drug shortage after FDA warning letter
|
| Wed, 05 Aug 2020 19:21:58: | AbbVie serves up Grand Slam tennis champion Serena Williams as new Ubrelvy spokesperson
|
| Wed, 05 Aug 2020 16:05:54: | Pfizer's Lorbrena makes play for earlier lung cancer use with Xalkori-topping data
|
| Wed, 05 Aug 2020 15:23:01: | Johnson & Johnson pledges 100M coronavirus vaccine doses to U.S. for $10 each
|
| Wed, 05 Aug 2020 14:52:44: | Moderna prices coronavirus shot at up to $37 per dose for small deals. What will big customers get?
|
| Wed, 05 Aug 2020 14:46:50: | Bayer's struggle to find Vitrakvi patients highlights broader diagnostics hurdles in pharma, likely exacerbated by COVID-19
|
